Decadron dosing for brain tumor

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Side effects with dexamethasone are common, and they increase in frequency and severity with increased dose and duration of therapy

2024-03-29
    Reversal or antidote for doxepin
  1. Intravenous dexamethasone was used at dose of 0
  2. Usual Adult Dose for Brain/Intracranial Tumor
  3. 1-2 mg/kg IV/IM once; maintenance: 1-1
  4. 1-2 mg/kg IV/IM once; maintenance: 1-1
  5. Decadron is available in strengths of 0
  6. Treatment of brain metastases has become increasingly
  7. Dexamethasone